J8520 Capecitabine - CanMED: HCPCS

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Medication Information

CanMED: HCPCS

Generic Name:

Capecitabine

Brand Name:

Xeloda

Strength:

150 mg

HCPCS:

J8520

SEER*Rx Category:

Chemotherapy

Major Drug Class:

Antimetabolite

Minor Drug Class:

Pyrimidine Analog

Oral (Y/N):

Yes

FDA Approval Year:

1998

FDA Discontinuation Year:

CMS Effective Date:

Jan. 1, 2000

CMS Discontinuation Date:

Status:

In Use